Serum MFAP4, a Novel Potential Biomarker for Liver Cirrhosis Screening, Correlates with Transient Elastography in NAFLD Patients
JGH OPEN(2023)
Key words
cirrhosis,MFAP4,non-alcoholic fatty liver disease,serum biomarker,transient elastography
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined